Moreover, the presence of PI3K pathway alterations was associated with worse prognosis in Black patients with HR+, HER2-negative breast cancer, underscoring the clinical impact of underutilizing genotype-directed therapy in this population. The gene discussed is PIK3CA; the disease is breast cancer.